RegWardenFDA facility compliance records
Facility

MICRO TYPING SYSTEMS, INC.

1 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2016: 1 inspections; 2024: 1 recalls1201620172018201920202021202220231202420252026
  • Recalls (1)
  • Inspections (1)

Devices registered here (1)

  • Kit, Quality Control For Blood Banking Reagents
    Product code KSF (opens in a new tab) · Class II · Hematology · 21 CFR 864.9650

Recalls & enforcement

  • Class IIOngoing2024-04-09
    T3 Reagent Packs used with Free T3 Calibrators may produce positively biased results for patient and quality control samples. The positive bias may cause erroneous patient results or a delay in testing that may impact patient management, clinical assessment, and the results of ot…

FDA inspections (1)

  • VAI2016-01-15
    Voluntary Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “MICRO TYPING SYSTEMS, INC. (FEI 1000132079) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1000132079-micro-typing-systems-inc/

Not open yet

Alerts for MICRO TYPING SYSTEMS, INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.